ANKRD47 can engage multiple cellular pathways to facilitate the activation of this protein. Forskolin serves as a direct activator of adenylyl cyclase, thereby increasing cyclic AMP (cAMP) levels within the cell. Elevated cAMP triggers a cascade of events leading to the activation of protein kinase A (PKA). The activated PKA then phosphorylates target proteins, which may include ANKRD47, thereby enhancing its activity. Similarly, IBMX acts to maintain high levels of cAMP by inhibiting phosphodiesterases that degrade cAMP. This inhibition ensures that PKA remains active, providing a sustained stimulus for the activation of ANKRD47. Adrenergic agonists like Isoproterenol and Epinephrine also increase cAMP production by stimulating beta-adrenergic receptors, which indirectly promotes the activation of ANKRD47 via PKA signaling. In parallel, PGE1, through its own receptor interactions, initiates a rise in cAMP levels, which further emphasizes the role of cAMP as a pivotal molecule in the activation of ANKRD47 through PKA.
Activators of other kinases also play a role in the activation of ANKRD47. Rolipram, by selectively targeting phosphodiesterase 4, leads to an accumulation of cAMP, thus enhancing PKA activity and possibly facilitating the activation of ANKRD47. Anisomycin triggers the MAPK signaling pathways, which can activate various transcription factors or kinases that may directly phosphorylate ANKRD47, resulting in its activation. PMA, by activating PKC, could initiate a phosphorylation cascade affecting ANKRD47. Thapsigargin and Ionomycin, which disturb calcium homeostasis, can activate calcium-dependent protein kinases that may lead to the phosphorylation and subsequent activation of ANKRD47. Lastly, phosphatase inhibitors such as Calyculin A and Okadaic Acid prevent the dephosphorylation of proteins, which would normally counteract kinase activity. By inhibiting these phosphatases, the phosphorylation state within the cell is tipped towards a more active state, which could include the hyperphosphorylation and activation of ANKRD47, maintaining it in an activated state. These chemicals collectively ensure that through various signaling pathways, ANKRD47 becomes activated, fulfilling diverse cellular functions.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Directly activates adenylyl cyclase, increasing cAMP levels which can lead to the activation of ANKRD47 through cAMP-dependent protein kinase A (PKA) signaling, as PKA can phosphorylate various proteins including those in the ANKRD family. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $159.00 $315.00 $598.00 | 34 | |
Non-specifically inhibits phosphodiesterases, preventing cAMP degradation, which supports the PKA pathway activation potentially leading to the activation of ANKRD47. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $27.00 $37.00 | 5 | |
Acts as an agonist for beta-adrenergic receptors, leading to increased cAMP production and subsequent activation of PKA, which may phosphorylate and activate ANKRD47 as part of downstream signaling. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $40.00 $102.00 $197.00 $1739.00 $16325.00 | ||
Binds to adrenergic receptors, increasing cAMP and activating PKA, which could phosphorylate components including ANKRD47 as part of the signaling cascade. | ||||||
PGE1 (Prostaglandin E1) | 745-65-3 | sc-201223 sc-201223A | 1 mg 10 mg | $30.00 $142.00 | 16 | |
Prostaglandin E1 binds to its receptors leading to increased cAMP levels, potentially resulting in PKA activation and subsequent phosphorylation and activation of ANKRD47. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $75.00 $212.00 | 18 | |
Selectively inhibits phosphodiesterase 4, leading to increased cAMP levels, possibly leading to PKA-mediated activation of ANKRD47. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $97.00 $254.00 | 36 | |
Activates MAPK signaling pathways, which can lead to the activation of transcription factors and other proteins that could phosphorylate and activate ANKRD47. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
Activates protein kinase C (PKC), which may lead to downstream signaling resulting in the phosphorylation and activation of ANKRD47. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
Induces ER stress leading to the activation of the unfolded protein response, which can modify signaling pathways and potentially lead to the activation of proteins like ANKRD47. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
Increases intracellular calcium levels, which can activate calcium-dependent protein kinases that might phosphorylate and activate ANKRD47. |